ANDA Performance/Operations Update (3of27) Generic Drugs Forum April 2018

Edward “Ted” Sherwood, director of CDER’s Office of Generic Drugs Office of Regulatory Operations, provides an update on key performance metrics related to FDA’s Abbreviated New Drug Application program and an overview of some Generic Drug User Fee II metrics. Learn more at https://www.fda.gov/drugs/cder-small-... --_______________________________ FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research. Upcoming training and free continuing education credits: https://www.fda.gov/cdersbia CDER SBIA 2018 Playlist:    • 2018 CDER Small Business and Industry Assi...   LinkedIn:   / cder-small-business-and-industry-assistance   Training resources: https://www.fda.gov/cderbsbialearn Twitter:   / fda_drug_info   CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm... Email: [email protected] Phone: (301) 796-6707 I (866) 405-5367